Nine Masts Capital »

Pmv Pharmaceuticals shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $21k 17k 1.25

More positions owned by Nine Masts Capital

Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Norfolk Southern (NSC)
Fox Corp Cl B Com (FOX)
Invesco Qqq Tr Unit Ser 1 (Principal) (QQQ)
Cyberark Software SHS (CYBR)
Nio Note 4.625%10/1 (Principal)
Qorvo (QRVO)
Ase Technology Hldg Sponsored Ads (ASX)
GSK Sponsored Adr (GSK)
Zillow Group Cl C Cap Stk (Z)
EXACT Sciences Corporation (EXAS)
Ryanair Holdings Sponsored Adr (RYAAY)
Jd.com Spon Ads Cl A (JD)

View all positions for Nine Masts Capital

Top funds holding Pmv Pharmaceuticals

BML Capital Management
OrbiMed Advisors
Tang Capital Management
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Vanguard Group
Acadian Asset Management
Stonepine Capital Management
BlackRock
Jacobs Levy Equity Management
Jane Street
Aldebaran Capital
Marshall Wace
Geode Capital Management

View all funds holding Pmv Pharmaceuticals